Novobiotic Pharmaceuticals Scientific Advisory Board

Stanley Falkow, Ph.D., Stanford University, Member of the National Academy of Sciences, is an expert in infectious diseases.

Arnold L. Demain, Ph.D., Drew University, Member of the National Academy of Sciences, is an expert in antiinfectives.

Jon Clardy, Ph.D., Academic Director, Initiative for Chemical Genetics, Harvard University, is an expert in natural product chemistry.

Robert C. Moellering, Jr., M.D., Physician-in-Chief and Chairman of the Department of Medicine at the Beth Israel Deaconess Medical Center (BIDMC), and President and CEO of Harvard Medical Faculty Physicians, is an expert in antimicrobial chemotherapy.

Steven J. Projan, Ph.D., Wyeth Research, is an expert in antimicrobial agent drug discovery.